Enesi and BARDA to co-develop flu vaccines by Anna Smith | Apr 16, 2019 | News | 0 The public-private partnership aims to provide a cost-effective technological innovation. Read More
UK pharma Enesi links with Australian biotech Sementis by Selina McKee | Nov 5, 2018 | News | 0 UK group Enesi Pharma has signed a deal with Australian biotech Sementis to develop solid dose versions of the latter’s lead peanut hypoallergy vaccine and its chikungunya/Zika vaccine candidates. Read More